{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:22:55Z","timestamp":1775751775396,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1097\/md.0000000000007196","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T10:23:45Z","timestamp":1498040625000},"page":"e7196","source":"Crossref","is-referenced-by-count":25,"title":["Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma"],"prefix":"10.1097","volume":"96","author":[{"given":"Mehdi","family":"Maanaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Saint-Jacques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane","family":"Gnemmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Lionet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Hazzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Provot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-34-20210226","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"R2-34-20210226","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ckj\/sfv149","article-title":"Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network","volume":"9","author":"Wanchoo","year":"2016","journal-title":"Clin Kidney J"},{"key":"R4-34-20210226","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.molonc.2011.01.005","article-title":"Biological challenges of BRAF inhibitor therapy","volume":"5","author":"Puzanov","year":"2011","journal-title":"Mol Oncol"},{"key":"R5-34-20210226","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaoncol.2015.1713","article-title":"Nephrotoxicity of the BRAF inhibitors vemurafenib and dabrafenib","volume":"1","author":"Jhaveri","year":"2015","journal-title":"JAMA Oncol"},{"key":"R6-34-20210226","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/cncr.28709","article-title":"Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients","volume":"120","author":"Launay-Vacher","year":"2014","journal-title":"Cancer"},{"key":"R7-34-20210226","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00280-016-3086-7","article-title":"New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma","volume":"78","author":"Teuma","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"R8-34-20210226","doi-asserted-by":"crossref","first-page":"e4988","DOI":"10.1097\/MD.0000000000004988","article-title":"Systemic vasculitis associated with vemurafenib treatment: case report and literature review","volume":"95","author":"Mirouse","year":"2016","journal-title":"Medicine"},{"key":"R9-34-20210226","doi-asserted-by":"crossref","first-page":"F93","DOI":"10.1152\/ajprenal.00345.2007","article-title":"Identification of BRAF as a new interactor of PLCepsilon1, the protein mutated in nephrotic syndrome type 3","volume":"294","author":"Chaib","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R10-34-20210226","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jmg.2009.076166","article-title":"Mutational analysis of the PLCE1 gene in steroid resistant nephrotic syndrome","volume":"47","author":"Boyer","year":"2010","journal-title":"J Med Genet"},{"key":"R11-34-20210226","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette","year":"2003","journal-title":"Kidney Int"},{"key":"R12-34-20210226","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11926-015-0545-9","article-title":"Drug-induced vasculitis: new insights and a changing lineup of suspects","volume":"17","author":"Grau","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R13-34-20210226","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08916930903374832","article-title":"Key role of ERK pathway signaling in lupus","volume":"43","author":"Gorelik","year":"2010","journal-title":"Autoimmunity"},{"key":"R14-34-20210226","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/art.10833","article-title":"Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling","volume":"48","author":"Deng","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:52:25Z","timestamp":1620960745000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201706230-00034"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":13,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007196","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}